PLoS ONE (Jan 2013)

SIRT1 catalytic activity has little effect on tumor formation and metastases in a mouse model of breast cancer.

  • Katherine V Clark-Knowles,
  • Danielle Dewar-Darch,
  • Karen E Jardine,
  • Michael W McBurney

DOI
https://doi.org/10.1371/journal.pone.0082106
Journal volume & issue
Vol. 8, no. 11
p. e82106

Abstract

Read online

The protein deacetylase SIRT1 has been implicated in the regulation of a large number of cellular processes that are thought to be required for cancer initiation and progression. There are conflicting data that make it unclear whether Sirt1 functions as an oncogene or tumor suppressor. To assess the effect of SIRT1 on the emergence and progression of mammary tumors, we crossed mice that harbor a point mutation that abolishes SIRT1 catalytic activity with mice carrying the polyoma middle T transgene driven by the murine mammary tumor virus promoter (MMTV-PyMT). The absence of SIRT1 catalytic activity neither accelerated nor blocked the formation of tumors and metastases in this model. There was a lag in tumor latency that modestly extended survival in Sirt1 mutant mice that we attribute to a delay in mammary gland development and not to a direct effect of SIRT1 on carcinogenesis. These results are consistent with previous evidence suggesting that Sirt1 is not a tumor promoter or a tumor suppressor.